What are Organogenesis Holdings Inc.'s profit margins?

Organogenesis Holdings Inc. (ORGO) runs a 75.9% gross margin and a 0.5% operating margin, with a 0.5% net margin.

Where do Organogenesis Holdings Inc.'s ratios come from?

Every ratio is computed from Organogenesis Holdings Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Organogenesis Holdings Inc. ORGO Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Profitability
Operating margin	7.9%—	——	——	4.9%-10.5pp
Net margin	6.6%+6.4pp	0.2%—	——	3.4%-16.7pp
Returns
Return on equity	13.2%+12.8pp	0.3%—	——	6.1%-43.0pp
Return on invested capital	12.4%—	——	——	6.3%-30.5pp
Efficiency
Asset turnover	1×0.0×	1×+0.1×	1×-0.1×	1×-0.3×
Liquidity
Current ratio	3.6×-0.1×	3.7×+0.9×	2.8×-0.2×	3×+0.2×
Leverage
Debt-to-equity	0.3×-0.2×	0.5×+0.1×	0.4×0.0×	0.4×-0.1×
Net debt / EBITDA	-0×—	——	——	0.6×+0.4×
Per Share
Book value per share	$2.30+15.4%	$2.00-4.9%	$2.10+4.6%	$2.01+11.1%
Valuation
Market capitalization	$312.68M-23.7%	$402.32M-24.9%	$535.45M+52.0%	$352.17M-70.4%
Price / earnings	115×—	467.3×—	——	22.7×+10.0×
Price / sales	0.6×-0.3×	0.8×-0.4×	1.2×+0.5×	0.8×-1.8×
Price / book	1.3×-0.4×	1.5×-0.4×	1.9×+0.6×	1.3×-3.6×
EV / EBITDA	14.1×—	——	——	13.1×-1.4×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Organogenesis Holdings Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Organogenesis Holdings Inc.'s profit margins?: Organogenesis Holdings Inc. (ORGO) runs a 75.9% gross margin and a 0.5% operating margin, with a 0.5% net margin.
Where do Organogenesis Holdings Inc.'s ratios come from?: Every ratio is computed from Organogenesis Holdings Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.